Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era | Zendy

Liset Olarte | Zendy; William J. Barson | Zendy; Ryan M Barson | Zendy; José R. Romero | Zendy; John S. Bradley | Zendy; Tina Q. Tan | Zendy; Laurence B. Givner | Zendy; Jill A. Hoffman | Zendy; Philana Ling Lin | Zendy; Kristina G. Hultén | Zendy; Edward O. Mason | Zendy; Sheldon L. Kaplan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era

Author(s) -

Liset Olarte,

William J. Barson,

Ryan M Barson,

José R. Romero,

John S. Bradley,

Tina Q. Tan,

Laurence B. Givner,

Jill A. Hoffman,

Philana Ling Lin,

Kristina G. Hultén,

Edward O. Mason,

Sheldon L. Kaplan

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix115

Subject(s) - medicine , pneumococcal conjugate vaccine , pneumococcal pneumonia , pneumonia , streptococcus pneumoniae , serotype , pediatrics , confidence interval , antibiotics , immunology , microbiology and biotechnology , biology

The impact of PCV13 on a number of clinical aspects of pneumococcal pneumonia (PP) in children has not been reported. We compared the serotype distribution, antibiotic susceptibility, and outcomes of children with PP 4 years before and 4 years after the introduction of PCV13.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research